Research and Development ASPH (@RDASPFT) header
Research and Development ASPH (@RDASPFT) profile picture

Research, Innovation And Development Department for Ashford & St Peter's Hospitals NHS Foundation Trust

Chertsey, UK
Joined July 2026
Photo by Research and Development ASPH (@RDASPFT)Photo by Research and Development ASPH (@RDASPFT)Photo by Research and Development ASPH (@RDASPFT)Photo by Research and Development ASPH (@RDASPFT)Photo by Research and Development ASPH (@RDASPFT)Photo by Research and Development ASPH (@RDASPFT)Photo by Research and Development ASPH (@RDASPFT)Photo by Research and Development ASPH (@RDASPFT)Photo by Research and Development ASPH (@RDASPFT)Photo by Research and Development ASPH (@RDASPFT)
A posterior fat pad sign on a lateral elbow radiograph is never normal. It means an effusion, and in an adult that usually means a radial head fracture you cannot see yet. An isolated anterior fat pad can be normal.
The terrible triad of the elbow: posterior dislocation, radial head fracture, coronoid fracture. Each element has to be addressed for the joint to stay reduced. Treating the dislocation alone is what makes it terrible.
1
Anatomical snuffbox tenderness with a normal radiograph is a scaphoid fracture until proven otherwise. The first film is often clean. Immobilise and re-image, or go straight to MRI. The cost of missing it is a non-union in a young wrist.
Research-active NHS trusts had lower risk-adjusted mortality for emergency admissions — even after adjusting for staffing & structure (Ozdemir et al., PLoS ONE 2015). At ASPH, research is part of how we make care safer. 🔬 #Research #NHS #PatientSafety
Do research-active hospitals deliver better care? A 2024 systematic review of 95 studies found 86 reported positive results — better care processes & patient outcomes (Boaz et al.). The evidence behind our R&D strategy at ASPH. #Research #NHS #Innovation
1
Across 129 NHS trusts, patient recruitment into interventional trials was the strongest research link to lower mortality & better CQC ratings (Jonker & Fisher, Public Health 2018). Opening trials = safer care. Thank you to all who take part. 🙏 #ClinicalTrials #NHS
More research, greater benefit. Across 129 NHS trusts, risk-adjusted survival rose step-by-step from the lowest to the highest third for research funding & recruitment (Ozdemir et al., PLoS ONE 2015) — a "dose effect" echoed by Boaz et al. 2024. #Research #NHS #ASPH
4
Research-active NHS trusts had more doctors, nurses, critical-care beds & operating theatres — and lower risk-adjusted mortality (Ozdemir et al., PLoS ONE 2015). Research grows alongside clinical capacity, not apart from it. #Research #NHS #ASPH
3
What turns single studies into system-wide gains? Research networks. A 2024 review of 95 studies found network-level investment central to linking research to better care & outcomes (Boaz et al.). Our R&D connects into the NIHR network. #NIHR #NHS #Research
1
Cancer is the most-studied field in the research-and-outcomes literature — and the evidence is largely positive, linking research engagement to better care & outcomes (Boaz et al., 2024). A reason we prioritise oncology research at ASPH. #CancerResearch #NHS #ASPH
2
Research improves more than survival. Greater interventional research activity is linked to better CQC ratings across 129 NHS trusts (Jonker & Fisher 2018), and reviews report better care processes too (Boaz et al. 2024). Better care, day to day. #NHS #QualityOfCare
2
Research-active teams deliver safer, higher-quality care (Ozdemir 2015; Boaz 2015, 2024) — and it depends on people. Colleagues: open or join a study. Patients: ask your team about research you could take part in. #ClinicalResearch #NHS #ASPH
A cheap steroid. An NHS trial. Lives saved worldwide. The RECOVERY trial showed dexamethasone cut 28-day deaths in ventilated Covid-19 patients from 41.4% to 29.3% (RECOVERY Collaborative Group, NEJM 2021). Why hospital research matters. #RECOVERY #NHS #ClinicalTrials
2
What happens in a clinical trial? Phase 1: safety & dose (small group) Phase 2: does it work? (larger) Phase 3: vs standard care (large) Phase 4: monitoring after approval Voluntary, fully explained, withdraw anytime. Ask your team. #ClinicalTrials #NHS #ASPH
3
Research should represent everyone it aims to help. A 2024 review found the evidence is still dominated by the Global North, and flagged equity (Boaz et al.). Inclusive recruitment — across age, sex & ethnicity — makes research fairer & stronger. #HealthEquity #NHS
7
Sometimes the key finding is that an operation doesn't help. CSAW — a UK trial in 32 NHS hospitals — found a common shoulder decompression op was no better than placebo surgery (Beard et al., Lancet 2018). #ShoulderSurgery #NHS
5
For many proximal humerus (shoulder) fractures, surgery is not the answer. The NHS PROFHER trial found surgery gave no better outcomes than non-surgical care & wasn't cost-effective (BJJ 2016). #Orthopaedics #NHS
2
'Negative' trials are among the most valuable research we do. UK shoulder trials (CSAW, PROFHER) found some operations work no better than simpler care — fewer unnecessary surgeries. Knowing what to stop matters. #EvidenceBasedMedicine #NHS
8
Example of a sensitivity and specificity table evaluating a new test (culture swab) for diagnosis of a disease (tibia infection).
2
Positioning, nerve blocks and the time of day: three studies on perioperative safety in shoulder surgery from Professor Mohamed Imam and colleagues. researchgate.net/publication… @MoAImam #PatientSafety #Anaesthesia #ShoulderSurgery
2